A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

In the ongoing fight against HIV, scientists have taken a new step toward long-term control of the virus. Researchers have ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus itself, offering hope for future gene therapy without daily meds.

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...

South Africa might be cushioned from the global fallout in reduced funding for HIV prevention and treatment, but it has not been spared the effects, a global health report has found.

“U=U” stands for “Undetectable = Untransmittable,” a public health message endorsed by UNAIDS, the WHO and other organizations, which means a person with HIV who is on effective antiretroviral therapy ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.